FindMyKOL
Clinical trialNCT04717492CompletedObservational

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

SponsorUniversity of MinnesotaEnrollment584Pulmonary Disease, Chronic Obstructive
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their underlying lung disease. Patients with will be identified via the EMR. 571 participants will be enrolled.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

  • University of California, San Francisco-Fresno

    Fresno, California, United States

  • la Biomed at Harbor-Ucla Medical Center

    Los Angeles, California, United States

  • University of California at San Francisco

    San Francisco, California, United States

  • National Jewish Medical & Research Center

    Denver, Colorado, United States

  • North Florida/south Georgia Veterans Health System

    Gainesville, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Louisiana State University

    New Orleans, Louisiana, United States

  • University of Maryland Baltimore

    Baltimore, Maryland, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Healthpartners Research Foundation

    Minneapolis, Minnesota, United States

  • Veteran'S Administration Medical Center

    Minneapolis, Minnesota, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Newyork-Presbyterian Brooklyn Methodist Hospital

    Brooklyn, New York, United States

  • New York Presbyterian/queens

    Flushing, New York, United States

  • Columbia University

    New York, New York, United States

  • Weill Cornell Medicine

    New York, New York, United States

  • Cincinnati Va Medical Center

    Cincinnati, Ohio, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Temple University Lung Center

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • University of Utah Health Sciences Center

    Salt Lake City, Utah, United States

  • the University of Vermont

    Burlington, Vermont, United States

  • University of Washington School of Medicine

    Spokane, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Jun 2020
Primary completion
18 May 2022
Completion
2 Dec 2022
Last update posted
31 Jan 2025
Registered enrollment
584
Registry id
NCT04717492

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.